Background: Until recently, there was a lack of a uniform definition for acute kidney injury (AKI). The 'acute renal injury/acute renal failure syndrome/severe acute renal failure syndrome' criteria, the Risk -Injury -Failure -Loss of kidney functionEnd stage renal disease (RIFLE) criteria and the Acute Kidney Injury Network (AKIN) classification were the most recent proposals. Aim: To compare the performance of the different AKI definitions. Design and Methods: Application of the three most recent AKI definitions to 41 972 critically ill ICU patients and comparison of their performance. Results: Incidence and outcome of AKI varied depending on the criteria. The RIFLE and AKIN classification led to similar total incidences of AKI (35.9 vs. 35.4%) but different incidences and outcomes of the individual AKI stages. Multivariate analysis showed that the different stages of AKI were
Introduction
The lack of a uniform definition for acute kidney injury (AKI) is considered to be one of several reasons for conflicting epidemiological data and absence of therapeutic progress in the field of AKI. In the past 10 years, the renal and critical care community have experienced a journey from proposed AKI criteria in 2001 to the Risk -Injury -FailureLoss of kidney function -End stage renal disease (RIFLE) classification in 2004 and the Acute Kidney Injury network (AKIN) classification in 2007. [1] [2] [3] In 2001, Bellomo and colleagues proposed criteria which distinguished between three different stages of AKI [acute renal injury (ARI), acute renal failure syndrome (ARFS) and severe acute renal failure syndrome (SARFS)] based on absolute values of serum creatinine, serum urea, urine output and/or treatment with renal replacement therapy (RRT) ( Table 1) . 1 The criteria defined AKI as well as acute-on-chronic renal disease.
In 2004, the Acute Dialysis Quality Initiative (ADQI) working party published the RIFLE criteria, which differentiate between three severity classes and two outcome stages of AKI (Table 2) . 2 The classification is based on relative changes of serum creatinine or estimated glomerular filtration rate (GFR) and absolute urine volumes. If previous creatinine results are not available, an assumption can be made that baseline renal function was normal. Clinical studies with total enrolment of >70 000 patients confirmed a close correlation between the RIFLE criteria and mortality with a stepwise increase in relative risk of death from 2.4 in patients with RIFLE-Risk to 6.37 for RIFLE-Failure. 4 In 2005, Chertow and colleagues demonstrated that even smaller changes in serum creatinine than suggested in the RIFLE classification, were indicative of significant renal dysfunction. 5 They found that a rise in serum creatinine by !0.3 mg/dl (26.4 mmol/l) during hospital admission was independently associated with a 4.1 increased odds ratio (OR) for in-hospital death. The AKI Network revised the RIFLE criteria and incorporated Chertow's important finding into the AKIN classification (Table 3) . 3 The creation of these definitions was hailed as an important step forward to facilitate high quality epidemiological, preventative and therapeutic trials in AKI. We previously applied the different classifications to a large population of >40 000 intensive care unit (ICU) patients and confirmed that all three correlated with outcome. [6] [7] [8] The aim of this article is to compare the performance of the different classifications directly and to illustrate some strengths and limitations which should be kept in mind when using the criteria.
Materials and methods

Study population
We analysed the data of 41 972 adult patients admitted to 22 ICUs in the UK and Germany between June 1989 and October 1999. Eight hundred patients were excluded from the analysis (797 patients with dialysis dependent end-stage renal failure and three patients with missing data).
Data analysis
The exact methods of data extraction were described in detail in the original papers.
6-8 AKI was defined according to serum creatinine values obtained during stay in ICU. We did not have access to any blood results before admission to ICU and also did not have 6-hourly urine results. 
Ethics approval
The local research and ethics committee confirmed that informed consent was not required because the study included neither an intervention nor breach of privacy or anonymity.
Statistical analysis
The statistical analyses are outlined in detail in the original papers. [6] [7] [8] Using multivariate logistic regression analysis, independent predictors of all-cause hospital mortality were identified. Calibration was assessed by the Hosmer-Lemeshow 'Goodness-offit' statistic for significance (P > 0.05) and discrimination was evaluated by determination of the area under the receiver operating characteristics (ROC) curve. The statistical package SPSS (Version 14.0, Woking, UK) was used for all analyses.
Results
The incidence and outcome of AKI depended on the criteria used ( Table 4 ). The RIFLE criteria and the AKIN classification led to similar total incidences of AKI but different incidences and outcomes of the individual AKI stages. Similarly, mortality rates of the individual stages differed depending on the criteria used.
Only the AKIN classification demonstrated a stepwise increase in risk of mortality. Multivariate analyses showed that different stages of AKI were independently associated with outcome. The worst stage of AKI was associated with an OR for hospital mortality of 1.59-2.27. Non-surgical admission, emergency surgery, maximum number of failed organ systems and mechanical ventilation were consistently associated with the highest risk of hospital mortality. The area under the ROC was consistently >80%.
All classifications had the risk of not identifying patients with definite progressive creatinine rises as AKI. Reasons were the use of absolute creatinine values (i.e. the ARI/ARFS/SARFS criteria) or a narrow time period (i.e. the AKIN classification).
Discussion
Designing criteria for a dynamic condition like AKI is a major undertaking. The validity of any classification for AKI depends on whether it is able to clearly differentiate between normal renal function and different stages of AKI, has objective cut-off criteria which are easy to ascertain and not ambiguous, and has prognostic properties. Application of three different classifications for AKI to the same database showed that incidences of AKI and associated outcomes varied depending on the definition used. However, all classifications confirmed a correlation between severity of AKI and prognosis. Even when controlling for confounding factors in a multiple variable regression analysis, severe AKI was an independent risk factor for mortality.
This analysis also shows that all three AKI classifications have some shortcomings. Using the ARI/ ARFS/SARFS criteria with absolute cut-off values for serum creatinine, patients with definite AKI (for instance, patients with a rise in serum creatinine from a baseline value of 50 mmol/l to 115 mmol/l indicating a fall in GFR by >50%) will not be identified unless they also have a relevant reduction in urine output. Similarly, patients receiving RRT are only classified as having AKI if they also fulfil the criteria for ARI or ARFS, i.e. have a serum creatinine >120 mmol/l and/or oliguria. We identified 100 patients in our database who were treated with RRT early (i.e. serum creatinine was still <120 mmol/l) but were subsequently classified as having 'no AKI' because the serum creatinine remained consistently <120 mmol/l as a result of RRT. A major criticism of the RIFLE classification is the recommendation to assume normal baseline renal function if previous creatinine results are not available. In this case, the premorbid serum creatinine can be calculated according to an assumed estimated GFR of 75 ml/min/1.72 m 2 derived from the 'modification of diet in renal disease (MDRD)' formula. 9, 10 First, this approach ignores the fact that a proportion of AKI patients may have pre-existing chronic kidney disease (CKD). Therefore, the incidence of AKI may be overestimated. Secondly, the MDRD formula was originally derived from patients with stable CKD with an average GFR of 40 ml/min/ 1.73 m 2 but has not been validated in patients with AKI and rapidly changing creatinine levels.
The classifications vary in the method of classifying patients on RRT. Clinical practice of RRT is known to be very variable with no consensus regarding optimal timing. [11] [12] [13] The RIFLE classification does not include RRT as a criterion, an approach which eliminates the subjective element. As a result, all RIFLE categories include patients on RRT: patients may be classified as RIFLE-Risk or even 'no AKI' if RRT is started early (so that serum creatinine levels are maintained near-normal) or as RIFLE-Failure if RRT is started later after serum creatinine has risen by >300%. The AKI Network decided to classify patients on RRT automatically as having the worst degree of AKI, independent of serum creatinine.
Apart from the inclusion of RRT as a specific criterion, the AKIN classification differs from the RIFLE criteria in five other aspects: (i) the inclusion of a 48-h window for the diagnosis of AKI, (ii) a smaller change in creatinine to qualify for the diagnosis of AKI, (iii) the elimination of the MDRD formula, (iv) differentiation between three stages of severity but no outcome categories and (v) no allowance for missing baseline creatinine levels.
A time frame is clearly necessary when deciding whether kidney injury is acute or chronic. CKD is traditionally defined as the presence of renal dysfunction for !3 months. It would follow that renal dysfunction during a <3 months period should be called 'acute renal disease'. The AKI Network chose a 48-h window to ensure that AKI was definitely 'acute'. In contrast, the RIFLE classification uses a 7-day window. The danger of these relatively narrow time windows is that patients with slowly progressive acute renal dysfunction are not identified correctly. In our analysis we noticed that 2014 patients who were classified as having 'no AKI' (as per AKIN classification), had serum creatinine levels >140 mmol/l of whom 316 patients even had values >270 mmol/l. Although some patients had a degree of pre-existing CKD, others had progressive rises in serum creatinine but not within the required time period. Using the AKIN classification with a 7-day period (similar to the RIFLE criteria) instead of a 48-h window, we observed an increase in the total incidence of AKI: 39.5% instead of 35.4%. It is likely that a longer time frame, i.e. 2-4 weeks would have identified even more patients.
The AKIN classification emphasizes that AKI should only be diagnosed after exclusion of hypovolaemia and obstruction. Although it can be difficult in retrospective analyses to be certain that these criteria were fulfilled, accurate fluid assessment remains a challenge in clinical practice, too. A small retrospective single-centre study attempted to evaluate the AKIN classification strictly and concluded that the association of AKI with hospital mortality was still significant even when fluid depletion was not strictly excluded.
14 During a 1-year period, 213 patients admitted to a medical ICU fulfilled the serum AE urine creatinine criteria for AKI. Only 123 patients had complete data on fluid challenges, including the administration of a minimum of 500 ml of volume expander during <1 h in response to oliguria or raised serum creatinine. The authors illustrated that the association of AKI with hospital mortality was still significant even when the appropriate fluid challenge requirement was discarded.
A major problem of all proposed AKI classifications is the fact that they aim to be diagnostic as well as prognostic, include subjective criteria, like 'treatment with RRT' and rely on serial measurements of serum creatinine as the determining parameter.
Serum creatinine not only depends on renal function but is also affected by non-renal factors like age, muscle bulk and volume of distribution. Furthermore, in the early phase of AKI, significant decreases in GFR only lead to small increases in serum creatinine due to the exponential relationship of serum creatinine and GFR. 15 Waikar et al. emphasized that the generation rate and dynamic changes of creatinine varied depending on underlying renal function. 16 Twenty-four hours after a 90% reduction in creatinine clearance, the rise in serum creatinine was 246% in patients with normal renal function, 174% in CKD stage II, 92% in CKD stage III and only 47% in patients with CKD stage IV. In patients with normal renal function, CKD stages I or II, a 30% reduction in creatinine clearance never led to a 50% increase in serum creatinine (the earliest stage of the RIFLE classification).
Macedo et al. highlighted the impact of fluid overload on serum creatinine. 17 In a group of 253 critically ill patients with AKI, the median cumulative fluid balance increased from 2.7 l on Day 2 to 6.5 l on Day 7. As a result of dilution, the measured creatinine values were significantly lower compared with creatinine values adjusted for fluid accumulation (8-57 mmol/l over time). The authors warned that this underestimation of serum creatinine values in fluid overloaded patients may delay the diagnosis of AKI. They suggested that serum creatinine values should be corrected for fluid accumulation to allow a more accurate determination of AKI in critically ill patients. Finally, serum creatinine levels are also affected by laboratory technologies used for measurement as well as interference by hyperbilirubinaemia and drugs (i.e. Cimetidine, Trimethoprim). 18, 19 Despite the problems associated with the use of creatinine, it is currently the most widely used parameter to describe renal function, especially since none of the other newer biomarkers of renal function have been fully established in clinical practice. The usefulness of urine criteria for the definition of AKI has been debated previously. 9, 20, 21 Proponents argue that urine output often portends renal dysfunction in critical care patients before changes in serum creatinine. 21 In contrast, critics point out that urine output is affected by volume status, intrinsic levels of antidiuretic hormone, presence of obstruction and use of diuretics. Also, urine output criteria can only be accurately assessed in patients with a urinary catheter. In a review of 10 studies using the RIFLE classification, patients with RIFLE-Risk based on the creatinine criteria had a worse prognosis than those in the same class defined by the urine output criteria alone. 22 This observation raises the question whether the urine criteria indeed add value and secondly, whether they are appropriately matched with serum creatinine criteria.
The AKI classifications in their current format do not specify the direction of change of creatinine values and do not differentiate between patients with a rising creatinine and patients with an initially high serum creatinine, which gradually falls. We found that within each AKI stage, ICU mortality was significantly higher in AKI patients with a rising creatinine compared with patients with AKI and falling creatinine levels. 8 The RIFLE and AKIN classification have been directly compared before. A previous study in 662 ICU patients showed that the AKIN classification identified more patients as having AKI compared with the RIFLE criteria. 23 Mortality was significantly higher for AKI defined by the RIFLE criteria. Bagshaw 24 They showed that the number of patients classified as having a degree of AKI in the first 24 h in ICU using either the AKIN or RIFLE classification, was similar with no major difference in sensitivity, robustness and predictive ability. Our analysis also found no difference in the total incidence of AKI between the AKIN classification and the RIFLE criteria using data from the total stay in ICU, but the incidences and outcomes of individual stages of AKI differed (Table 4) .
Most clinicians and researchers welcome the existing attempts and efforts to agree on consensus criteria for the diagnosis of AKI. However, it is important to emphasize that the identification of a particular AKI stage does not provide any information on aetiology and clinical management. AKI stage 1 as a result of cardiogenic shock is very different from AKI stage 1 due to crescentic glomerulonephritis with regards to necessary therapeutic intervention as well as prognosis. The efforts to agree on a definition for AKI should occur in parallel with ongoing education in the area of Critical Care Nephrology, including emphasis on diagnosing the aetiology of AKI.
There is also some concern that the existing criteria for AKI do not capture the full extent of acute kidney disease. CKD is traditionally defined as the presence of impaired renal function for !3 months. The RIFLE classification uses a 1-week window to define AKI which leaves patients with progressive but slow rises in creatinine over a longer period undiagnosed. As mentioned earlier, we found that all three AKI classifications failed to identify some patients with definite rises in serum creatinine consistent with AKI. Clearly more work is needed in the area of 'defining AKI' during the 3-month period outside the 48 h or 1-week period for AKI but before the 3 months cut-off when they can be labelled as having CKD.
In conclusion, the three most recent classifications for AKI confirm a correlation between severity of AKI and outcome. All three classifications have strengths and weaknesses and potential for not identifying patients with definite acute renal dysfunction. Future revisions of the criteria should include guidance on the direction of change, corrections for underlying CKD and fluid overload and guidance on how to define patients with slowly progressive renal dysfunction. Until new biomarkers for AKI are fully established in clinical practice, definitions of AKI are likely to rely on changes in serum creatinine AE urine output. The generation of AKI criteria and their validation should not distract from the need to explore the pathomechanism of different types of AKI and to search for therapies.
